Nature Communications (Aug 2016)

Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models

  • Michael J. D. Daniels,
  • Jack Rivers-Auty,
  • Tom Schilling,
  • Nicholas G. Spencer,
  • William Watremez,
  • Victoria Fasolino,
  • Sophie J. Booth,
  • Claire S. White,
  • Alex G. Baldwin,
  • Sally Freeman,
  • Raymond Wong,
  • Clare Latta,
  • Shi Yu,
  • Joshua Jackson,
  • Nicolas Fischer,
  • Violette Koziel,
  • Thierry Pillot,
  • James Bagnall,
  • Stuart M. Allan,
  • Pawel Paszek,
  • James Galea,
  • Michael K. Harte,
  • Claudia Eder,
  • Catherine B. Lawrence,
  • David Brough

DOI
https://doi.org/10.1038/ncomms12504
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 10

Abstract

Read online

NSAID-induced analgesia is typically induced by inhibition of COX enzymes. Here the authors show instead that fenamate NSAIDs inhibit the Nlrp3 inflammasome via an effect on volume-regulated anion channel function and also repurpose these drugs for therapeutic effect in rodent models of Alzheimer disease.